RxDoctor Payments DataLook up a doctor →

Brian Macgillivray

Family Medicine · San Antonio, TXNPI 1851374623

Payments from drug & device makers

$3,162,271in general payments, 2019–2025

Across 1,533 payments — averaging $2062.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$663K
  • AbbVie$631K
  • Sanofi US Services Inc.$476K
  • Novartis$404K
  • Pfizer$251K
  • Astellas Pharma Global Development$216K
  • plus $521K from 17 others
$91,992in research payments, 2019–2025

Across 107 payments — averaging $859.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ichnos Glenmark Innovation Inc$54K
  • Glenmark Pharmaceuticals Inc., USA$32K
  • Pfizer$6K
  • Lucid Diagnostics Inc.$500

General payments by program year

19
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,162,271 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Other family medicine in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →